The reporter learned from Guangzhou Pharmaceutical Group that Baiyunshan Hanfang, a subsidiary of Guangzhou Pharmaceutical Group, and Sun Yat-sen University and other units have built a complete integrated core technology system centered on supercritical CO2 extraction, industrial chromatographic separation, membrane separation, etc., successfully overcoming many common problems in traditional Chinese medicine extraction and separation, and solving the difficulties of engineering and automation in continuous production of supercritical CO2; the project also used industrial chromatographic separation technology for the production of vinblastine anti-tumor raw materials, increasing production capacity from grams to 100 kilograms.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.